Modulation of the Immune System for the Treatment of Glaucoma

BACKGROUND: At present intraocular pressure (IOP) lowering therapies are the only approach to treat glaucoma. Neuroprotective strategies to protect the retinal ganglion cells (RGC) from apoptosis are lacking to date. Substantial amount of research concerning the role of the immune system in glaucoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Bell, Katharina, von Thun, Nadine, Teister, Julia, Grus, Franz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120111/
https://www.ncbi.nlm.nih.gov/pubmed/28730968
http://dx.doi.org/10.2174/1570159X15666170720094529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120111/
https://www.ncbi.nlm.nih.gov/pubmed/28730968
http://dx.doi.org/10.2174/1570159X15666170720094529

Ejemplares similares